Advanced Non-Small Cell (Non squamous cell) Lung Cance
Conditions
Interventions
CDDP+PEM+BEV
Sponsors
Japanese Foundation for Cancer Research, the Cancer Institute Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Histologically or cytrologically confirmed diagnosis of NSCLC with a adeno or large cell carcinoma 2)No prior systemic treatment advanced NSCLC with documented Stage IIIB or Stage IV or recurrent disease 3)Tumors must have measurable disease by RECIST version 1.1 4)20 years of age or older to 75 years exclusive 5))ECOG performance status 0 or 1 6)No problem adequate organ function
Exclusion criteria
Exclusion criteria: 1)Subjects with interstitial pneumonia or pulmonary fibrosis. 2)Uncontrolled Active infection 3)No other active malignancies 4)Concurrent use of steroid therapy 5)Subjects with symptomatic brain metastases. 6)have had or require continuous oral administration of hemostat/have had or require injectable administration of hemostat 7)Uncontrolled pleural. 8)Have received radiation therapy to lesions of lung 9)Have a bleeding diathesis 10)Uncontrolled hypertension 11)Any other reason that,in the opinion of the investugator precludes the subject from participating in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ORR | — |
Countries
Japan
Contacts
Public ContactNoriko Yanagitani
anese Foundation for Cancer Research, the Cancer Institute Hospital Thoracic Oncology Center
Outcome results
None listed